AAAAAA
Results:
1-14
|
Results: 14
Authors:
SINZINGER H
NEUMANN I
OGRADY J
ROGATTI W
PESKAR BA
Citation: H. Sinzinger et al., EFFECTS OF PROSTAGLANDIN E-1 METABOLITES ON THE INDUCTION OF ARTERIALTHROMBORESISTANCE, PROSTAGLANDINS & OTHER LIPID MEDIATORS, 55(5-6), 1998, pp. 265-275
Authors:
CACHOVAN M
ROGATTI W
CREUTZIG A
DIEHM C
HEIDRICH H
SCHEFFLER P
WOLTERING F
Citation: M. Cachovan et al., TREADMILL TESTING FOR EVALUATION OF CLAUDICATION - COMPARISON OF CONSTANT-LOAD AND GRADED-EXERCISE TESTS, European journal of vascular and endovascular surgery, 14(4), 1997, pp. 238-243
Authors:
SINZINGER H
NEUMANN L
OGRADY J
ROGATTI W
PESKAR BA
Citation: H. Sinzinger et al., PGE(1)-INDUCED ARTERIAL THROMBORESISTANCE IS A VASCULAR PROPERTY AS IDENTIFIED BY CROSS-PERFUSION TECHNIQUE, Prostaglandins, leukotrienes and essential fatty acids, 56(4), 1997, pp. 325-330
Authors:
DIEHM C
BALZER K
BISLER H
BULLING B
CAMCI M
CREUTZIG A
GRUSS JD
HORSCH S
ODEMAR F
PIEHLER U
ROGATTI W
SCHEFFLER P
SPENGEL F
TREESE N
TUROWSKI A
WALDHAUSEN P
WEBER B
WEISS T
Citation: C. Diehm et al., EFFICACY OF A NEW PROSTAGLANDIN E(1) REGIMEN IN OUTPATIENTS WITH SEVERE INTERMITTENT CLAUDICATION - RESULTS OF A MULTICENTER PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL, Journal of vascular surgery, 25(3), 1997, pp. 537-544
Authors:
SINZINGER H
KARANIKAS G
PIRICH C
ROGATTI W
Citation: H. Sinzinger et al., VASCULAR PROSTAGLANDIN E-1-PRETREATMENT DECREASES THROMBOGENICITY WHILE PLATELET PRETREATMENT DOES NOT, Thrombosis and haemostasis, 1997, pp. 1921-1921
Authors:
CREUTZIG A
BULLINGER M
CACHOVAN M
DIEHM C
FORST HT
GRUSS JD
HORSCH S
ROGATTI W
SCHEFFLER P
SPENGEL F
STIEGLER H
Citation: A. Creutzig et al., IMPROVEMENT IN THE QUALITY-OF-LIFE AFTER IV PGE(1) THERAPY FOR INTERMITTENT CLAUDICATION, VASA, 26(2), 1997, pp. 122-127
Authors:
KRITZ H
OGUOGHO A
FITSCHA P
KALIMAN J
ROGATTI W
SINZINGER H
Citation: H. Kritz et al., PLATELET RESPONSE DURING PROSTAGLANDIN E-1-THERAPY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Thrombosis research, 87(2), 1997, pp. 257-261
Authors:
BULLINGER M
CACHOVAN M
CREUTZIG A
DIEHM C
GRUSS J
HEIDRICH H
KIRCHBERGER I
LOEPRECHT H
ROGATTI W
Citation: M. Bullinger et al., DEVELOPMENT OF A DISEASE-SPECIFIC INSTRUM ENT FOR THE ASSESSMENT OF QUALITY-OF-LIFE IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, VASA, 25(1), 1996, pp. 32-47
Authors:
SINZINGER H
FITSCHA P
KRITZ H
ROGATTI W
OGRADY J
Citation: H. Sinzinger et al., PROSTAGLANDIN E(1) DECREASES CIRCULATING ENDOTHELIAL-CELLS, Prostaglandins, 51(1), 1996, pp. 61-68
Authors:
SINZINGER H
KRITZ H
VIRGOLINI I
SCHMID P
ROGATTI W
Citation: H. Sinzinger et al., PROSTAGLANDIN E(1) INCREASES BINDING OF I-123 LOW-DENSITY-LIPOPROTEINTO THE HUMAN LIVER IN-VIVO, European Journal of Clinical Pharmacology, 49(6), 1996, pp. 515-520
Authors:
HEIDRICH H
BULLINGER M
CACHOVAN M
CREUTZIG A
DIEHM C
GRUSS JD
KIRCHBERGER I
LOEPRECHT H
ROGATTI W
Citation: H. Heidrich et al., QUALITY-OF-LIFE IN PERIPHERAL ARTERIAL OC CLUSIVE-DISEASE - MULTICENTER STUDY OF LIFE QUALITY BY A NEWLY DEVELOPED DISEASE-SPECIFIC QUESTIONNAIRE, Medizinische Klinik, 90(12), 1995, pp. 693-697
Authors:
RODRIGUES M
SINZINGER H
KRITZ H
PESKAR BA
OGRADY J
ROGATTI W
Citation: M. Rodrigues et al., PGE(O) INHIBITS COLLAGEN AND GLYCOSAMINOGLYCAN-SYNTHESIS IN THE RABBIT ARTERIAL-WALL, VASA, 24(4), 1995, pp. 333-336
Authors:
CACHOVAN M
SCHEFFLER P
GRUSS J
DIEHM C
ROGATTI W
Citation: M. Cachovan et al., EFFICACY OF A STANDARDIZED PHYSICAL-TRAIN ING PROGRAM IN INTERMITTENTCLAUDICATION, Wiener Klinische Wochenschrift, 106(16), 1994, pp. 517-520
Authors:
SINZINGER H
FLORES J
LUPATTELLI G
VIRGOLINI I
ROGATTI W
Citation: H. Sinzinger et al., SPONTANEOUS COURSE OF HUMAN ATHEROSCLEROTIC LESIONS MONITORED BY 123I-LABELING OF AUTOLOGOUS LOW-DENSITY LIPOPROTEINS, Thrombosis and haemostasis, 69(6), 1993, pp. 805-805
Risultati:
1-14
|